ORPH News

A total of 29 companies entered the public market this past week, the most ever in a single week. The week’s 11 IPOs were joined by 15 SPACs and three direct listings. Notable new IPO filings included TPG-backed antivirus provider McAfee (MCFE), Vista Equity’s IT software provider Datto (MSP), and three mortgage companies. ...read more

Orphazyme, a Danish late-stage biotech developing protein therapies for rare neurodegenerative diseases, raised $84 million by offering 7.6 million ADS equivalents at $11, below the as-converted last close of its shares on the Nasdaq Copenhagen (ORPHA). At pricing, the company raised -16% less in proceeds than anticipated. Orphazyme plans to list on the Nasdaq under the symbol...read more

Updated Monday, 9/28. 11 IPOs and two direct listings are scheduled to go public in the week ahead. The diverse group includes three foreign tech issuers, two biotechs, two US tech unicorns, a sporting goods retailer, an avocado supplier, a medical device maker, and a foreign education company. More SPACs will likely join the calendar as well. ...read more

Orphazyme, a Danish late-stage biotech developing protein therapies for rare neurodegenerative diseases, announced terms for its IPO on Monday. The Copenhagen, Denmark-based company plans to raise $100 million by offering 7.6 million ADSs at $13.13, the as-converted September 17th close of its shares on the Nasdaq Copenhagen (ORPHA). At the proposed price, Orphazyme would...read more